NewsEvents

Your Yourlocation: Home > Tiotropium bromide(136310-93-5) in the treatment of moderate to severe stable chronic obstructive pulmonary disease

Tiotropium bromide(136310-93-5) in the treatment of moderate to severe stable chronic obstructive pulmonary disease, the study found that, from the results of this study, in the moderate to severe stable chronic obstructive pulmonary disease clinical treatment, the use of tiotropium bromide to be treated, can effectively improve the patient's exercise tolerance and lung function, reduce the number of acute attack, while the adverse reactions are relatively small. The article published on 2015 18 issue of "Chinese Medicine Guide".

The aim of this study was to investigate and analyze the efficacy of tiotropium bromide(136310-93-5) in patients with moderate to severe stable chronic obstructive pulmonary disease researchers in our hospital in February 2011 to July 2013 were treated in 100 patients with moderate to severe stable chronic obstructive pulmonary disease patients as the research object, based on the analysis of clinical data and hospital sequencing were randomly divided the patients in the observation group were treated with tiotropium bromide, and after a period of treatment, the changes of lung function of the two groups were compared and analyzed. The patients in the observation group were treated with tiotropium bromide(136310-93-5), and the control group was treated with albuterol sulfate aerosol. And exercise endurance changes.

The results showed that after a period of treatment, the observation group to improve lung function was significantly better than the control group, the difference between the two significant statistically significant, P <0.05, while observation group significantly increased exercise tolerance.

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved